Avid Bioservices, Inc. Common Stock
CDMO
CDMO was delisted on the 4th of February, 2025.
193 hedge funds and large institutions have $1.26B invested in Avid Bioservices, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 74 increasing their positions, 59 reducing their positions, and 22 closing their positions.
5,415% more call options, than puts
Call options by funds: $4.69M | Put options by funds: $85K
25% more repeat investments, than reductions
Existing positions increased: 74 | Existing positions reduced: 59
18% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 22
2% more funds holding
Funds holding: 190 → 193 (+3)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
29% less capital invested
Capital invested by funds: $1.79B → $1.26B (-$525M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCM
Geneva Capital Management
Milwaukee,
Wisconsin
|
+$28.3M |
| 2 |
State Street
Boston,
Massachusetts
|
+$13.8M |
| 3 |
Morgan Stanley
New York
|
+$11.6M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$6.34M |
| 5 |
Jennison Associates
New York
|
+$5.94M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ICM
ISZO Capital Management
New York
|
-$64.4M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$10.7M |
| 3 |
Franklin Resources
San Mateo,
California
|
-$8.74M |
| 4 |
N
Nuveen
Charlotte,
North Carolina
|
-$4.61M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$4.43M |
CDMO Hedge Fund Activity: Q1 2022 in Review
193 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Avid Bioservices, Inc. Common Stock (CDMO) for Q1 2022, worth a combined $1.26B — down 29% from $1.79B a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new CDMO positions and 22 closed out — a net gain of 4 holders — while 74 added to existing stakes and 59 trimmed.
The largest buyer was Geneva Capital Management, opening a new position worth an estimated $28.3M. The largest seller was ISZO Capital Management, exiting entirely with an estimated $64.4M sold.
- 193 institutional investors held Avid Bioservices, Inc. Common Stock (CDMO) as of Q1 2022, up from 190 in Q4 2021.
- Funds reported $1.26B of Avid Bioservices, Inc. Common Stock stock for Q1 2022, down 29% quarter-over-quarter.
- 26 funds opened new Avid Bioservices, Inc. Common Stock positions in Q1 2022 and 22 closed out, a net change of +4 holders.
- The largest Avid Bioservices, Inc. Common Stock buyer in Q1 2022 was Geneva Capital Management, an estimated $28.3M added.
- The largest Avid Bioservices, Inc. Common Stock seller in Q1 2022 was ISZO Capital Management, an estimated $64.4M sold.
Based on aggregated 13F filings for Q1 2022.